Evidence map›Paper›PMID 35294447›Full record

ArticlePLoS computational biology2022

Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model.

Navid Mohammad Mirzaei, Navid Changizi, Alireza Asadpoure, Sumeyye Su, Dilruba Sofia, Zuzana Tatarova, Ioannis K Zervantonakis, Young Hwan Chang, Leili Shahriyari

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice.Journal of personalized medicine · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Navid Mohammad MirzaeiDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America.ORCID 0000-0002-0971-0514
Navid ChangiziDepartment of Civil and Environmental Engineering, University of Massachusetts, Dartmouth, Massachusetts, United States of America.ORCID 0000-0001-8003-5403
Alireza AsadpoureDepartment of Civil and Environmental Engineering, University of Massachusetts, Dartmouth, Massachusetts, United States of America.ORCID 0000-0003-0347-6349
Sumeyye SuDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America.ORCID 0000-0001-5221-413X
Dilruba SofiaDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America.ORCID 0000-0002-1279-1626
Zuzana TatarovaDepartment of Biomedical Engineering and OHSU Center for Spatial Systems Biomedicine (OCSSB), Oregon Health and Science University, Portland, Oregon, United States of America.ORCID 0000-0002-3128-7214
Ioannis K ZervantonakisDepartment of Bioengineering, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.ORCID 0000-0003-2386-9553
Young Hwan ChangDepartment of Biomedical Engineering and OHSU Center for Spatial Systems Biomedicine (OCSSB), Oregon Health and Science University, Portland, Oregon, United States of America.ORCID 0000-0001-8764-1959
Leili ShahriyariDepartment of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America.ORCID 0000-0001-6234-8449
University of Massachusetts Amherst · USOregon Health & Science University · USUniversity of Massachusetts Dartmouth · USUPMC Hillman Cancer Center · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Understanding the Impact of Microscale and Nanoscale Heterogeneity and ResistanceU54CA209988 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEMIR, EMEK, HEISER, LAURA MADELINE · 2017 to 2021
$10.3M
NCI NIH HHS 75N91019D00024NCI NIH HHS U54 CA209988
6 · The paper itself

Abstract

The most common kind of cancer among women is breast cancer. Understanding the tumor microenvironment and the interactions between individual cells and cytokines assists us in arriving at more effective treatments. Here, we develop a data-driven mathematical model to investigate the dynamics of key cell types and cytokines involved in breast cancer development. We use time-course gene expression profiles of a mouse model to estimate the relative abundance of cells and cytokines. We then employ a least-squares optimization method to evaluate the model's parameters based on the mice data. The resulting dynamics of the cells and cytokines obtained from the optimal set of parameters exhibit a decent agreement between the data and predictions. We perform a sensitivity analysis to identify the crucial parameters of the model and then perform a local bifurcation on them. The results reveal a strong connection between adipocytes, IL6, and the cancer population, suggesting them as potential targets for therapies.

Indexed as

Breast NeoplasmsAnimalsCell Line, TumorCytokinesDisease Models, AnimalFemaleHumansMiceTumor MicroenvironmentCytokines

Identifiers

PMID35294447
PMCPMC8959189
OpenAlexW4220726519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.